Discoveries Could Have Implications in the Diagnosis, Monitoring and Treatment of Alzheimer’s Disease, Chronic Traumatic Encephalopathy and Traumatic Brain Injury SAN DIEGO, March 5, 2014 /PRNewswire/ — Aethlon Medical, Inc. (otcqx:AEMD), and its diagnostic subsidiary, Exosome Sciences, Inc. (ESI), announced today ...
Read More »